Pancreatic Cancer Research

ResearcherThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteActive in the last 2 years

Sameek Roychowdhury

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8297-3038; OpenAlex author ID A5088856020; NIH RePORTER profile ID 10824399. Sources: ClinicalTrials.gov.

Their work

Papers
5 (first author 0, last author 2)
Trials
1 (principal investigator on 1)
Grants
1
Labs led
1
Collaborators
24
Papers, trials and grants by year

2023: 1 paper · 2024: 3 papers · 2025: 1 trial · 2026: 1 paper, 1 grant

Papers 5

  1. Nationwide Fully Decentralized Telemedicine Therapeutic Trial for Advanced Pancreatic Cancer: Implementation and First Enrollment. Last author DOI 10.1200/po-26-00364↗
  2. FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer. Last author DOI 10.1038/s41698-024-00683-x↗
  3. Serum MUC5AC Predicts Recurrence in Pancreatic Ductal Adenocarcinoma Patients on Neoadjuvant Chemotherapy Co-author DOI 10.20944/preprints202409.0945.v1↗
  4. Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and Outcomes. Co-author DOI 10.3390/ijms25169041↗
  5. Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake. Co-author DOI 10.1007/s10689-022-00300-5↗

Trials 1

  1. A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic… Principal investigator NCT06906562↗

Grants 1

  1. Clinical validation of FGFR-Dx in plasma cell-free DNA from patients with FGFR-altered advanced pancreatic cancer UH3CA313817↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zachary A. Risch · 2 shared papers, 2024–2026 · strength 0.45
  2. Upender Manne · 2 shared papers, 2024 · strength 0.31
  3. Kannan Thanikachalam · 2 shared papers, 2024 · strength 0.31
  4. Ashwini Kumar Esnakula · 2 shared papers, 2024 · strength 0.31
  5. Wancai Yang · 2 shared papers, 2024 · strength 0.31
  6. Lianbo Yu · 2 shared papers, 2024 · strength 0.31
  7. Ankur Sheel · 2 shared papers, 2024 · strength 0.31
  8. Ashish Manne · 2 shared papers, 2024 · strength 0.31
  9. Jordan M. Cloyd · 2 shared papers, 2024 · strength 0.31
  10. Anup Kasi · 2 shared papers, 2024 · strength 0.31
  11. Mary E. Dillhoff · 2 shared papers, 2024 · strength 0.31
  12. Anne M. Noonan · 2 shared papers, 2024 · strength 0.31
  13. Aslam M. Ejaz · 2 shared papers, 2024 · strength 0.31
  14. Ravi Kumar Paluri · 2 shared papers, 2024 · strength 0.31
  15. Shafia Rahman · 2 shared papers, 2024 · strength 0.31
  16. Arjun Gupta · 1 shared paper, 2026 · strength 0.28
  17. Leah Stein · 1 shared paper, 2024 · strength 0.17
  18. Davendra P. S. Sohal · 1 shared paper, 2024 · strength 0.15
  19. Eric David Miller · 1 shared paper, 2024 · strength 0.15
  20. Kenneth L Pitter · 1 shared paper, 2024 · strength 0.15
  21. Deepak Sherpally · 1 shared paper, 2024 · strength 0.15
  22. Heather Hampel · 1 shared paper, 2023 · strength 0.14
  23. Mitchell L. Ramsey · 1 shared paper, 2023 · strength 0.14
  24. Laith I. Abushahin · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.